#372 Breaking Barriers in Psychedelic Drug Research with George McBride founder of Clerkenwell Health

This week, James is joined by Dr. Meriem Sefta, PhD, Chief Diagnostics Officer at Owkin. Owkin is the first end-to-end AI-biotech company on a mission to understand complex biology and ensure every patient gets the right treatment using AI trained on world-class patient data through privacy-enhancing technologies.Learn more: https://www.owkin.com/diagnostics-approachApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by George McBride, co-founder and COO of Clerkenwell Health a psychedelic-specialty clinical research organisation and site network headquartered in London. George is a commercial barrister turned drug policy reform advocate and entrepreneur. He's played in a key role in the campaign to legalise medical cannabis in the UK at the NGO Volteface before founding Europe’s leading cannabis advisory firm, Hanway Associates and industry conference Cannabis Europa. Learn more about Clerkenwell Health: https://www.clerkenwellhealth.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Sokratis Papafloratos, CEO and founder of Numan. After founding and exiting previous companies, Sokratis founded Numan in 2018 to provide men with access to treatment for erectile dysfunction. His journey towards founding the company was fuelled by a personal realisation of the underserved nature of men's health and a desire to leverage technology for positive behavioural change and destigmatisation. Six years later, Numan has scaled and evolved into the UK’s biggest men’s digital healthcare ecosystem providing support for more than half a million people across a wide range of health conditions and concerns.Learn more: https://www.numan.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This Sunday, Charlie Wells, Founder and CEO of HelloSelf gives us his quick tips for entrepreneurs.Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Charlie Wells, Founder and CEO of HelloSelf. In what he calls his ‘before life’ Charlie studied neurobiology at Oxford before moving to London to work in healthcare marketing, then in 2011 a life-threatening brain haemorrhage changed everything. After surviving a coma and pioneering surgery, Charlie decided to make the most of his second chance, focusing on personal well-being, relationships and making a positive impact. HelloSelf was founded off the back of this, responding to the growing demand for mental health services. HelloSelf helps people feel better, faster, and stay better, longer, by pairing individuals with therapists through their clinical matching team, designing therapy to fit an individuals' unique needs.Get in touch with the HelloSelf team: http://www.helloself.comApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Vicky Demas, the CEO of identifeye HEALTH. Vicky has more than 20 years of experience developing and launching healthcare products. She joined identifeye HEALTH after leading the development of new products for GRAIL, a cancer screening company. identifeye HEALTH aims to harness health insights from the human eye to promote overall health and well-being using automation and advanced AI.Get in touch with Vicky via her LinkedIn: https://www.linkedin.com/in/vasiliki-vicky-demas/https://www.identifeye.healthApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Dr Anna Klepchukova, Chief Medical Officer at women's health unicorn Flo Health. Anna is a qualified M.D. with specialist expertise in anesthesiologist and intensive care. Coupled with a degree in Marketing, Anna has worked extensively across pharma taking on the role of Marketing Manager at Takeda before joining Flo Health as Chief Medical officer in 2017. Learn more: https://flo.health/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Dr Thomas Fuchs, Founder and Chief Scientist at Paige, a healthtech company using the power of AI to drive a new era of cancer discovery and treatment. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology.It's cloud-based platform transforms pathologists’ workflow and increases diagnostic confidence as well as productivity on a global scale.Learn more: https://paige.ai/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Dr Matt Wilson, former NHS doctor and Anaesthesiologist, and founder and CEO of uMed. uMed's mission is to improve the lives of those living with disease by enabling access to the data and insights needed to bring new therapies and innovations to patients. uMed's platform – which is embedded across a global network of healthcare institutions – combines routinely collected EMR data with outcomes collected directly from patients at-home. This provides researchers with a rich source of regulatory grade data that can be further augmented with the collection of custom endpoints to meet specific research criteria.http://www.umed.ioApply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health

This week, James is joined by Dr Malte Gerhold, Director of Innovation and Improvement at The Health Foundation, an independent charity committed to bringing about better health and health care for people in the UK. Malte leads the Foundation’s work to support radical innovation and improvement in health and care services, providing insights, practical resources and funding to enable change, including through new technologies and data. Malte is also a trustee of the Alzheimer’s Society, a member of the Sciana Health Leaders Network, and a Fellow of the RSA.Learn more: https://www.health.org.uk/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health